CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 6,106 shares (grant or award)
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- 4 Other acquisition Chief Scientific Officer acquired 462,150 shares (other)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Gift Director gave 1,280,917 shares (gift)
- 4 Grant or award Director acquired 10,244 shares (grant or award)
- 4 Conversion Director acquired 24,000 shares (conversion)
- 4 Conversion President and CEO acquired 30,000 shares (conversion)
- 4 Conversion Director acquired 24,000 shares (conversion)
- 4 Conversion Director acquired 12,000 shares (conversion)
- 4 Conversion Director acquired 200,000 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 20,000 shares (conversion)
- 4 Gift Director gave 1,195,905 shares (gift)
Page 11 of 29 · 576 filings